Home / Technology Platforms / Complex Formulation Technology Platforms / CR & SR & QR & TR Targeted Formulation Technology Platform

Operation

Mixing of Materials
Wet granulated/Dry Granulated
Dehydration
Pellet
Performing
Coating

Technology

Solid dispersion preparative technique of non-dissolvable drug
Increase stability of non-dissolvable drug
Self-emulsifying technology and Solidification
Enteric and SR Pellets
Bi-layer controlled release tablet.
SR Tablet
Colon-specific and floating oral delivery system 

Strength of SR, CR, TR targeted formulation

Make drug consistence in blood steady, Decrease toxic and side effects
According to short-half-life drug, Minimized administration frequency, Increase patient compliance 
Decrease total dose.

Our Technical Strength

Professinals:17 stuff with PhD and Master degree
First-rate facilities:
Patent: Fogangren has gained industrialized key technologies with independent  intellectual property

Research Projects

Esomeprazole Enteric and SR Pellets, Capsule and compound preparation
Paroxetine hydrochloride CR tablet
Compound Niacin Sustained-release Tablets
Tacrolimus self-emulsifying Tablet, Tacrolimus SR Tablet
Budesonide Colon-specific Release Capsule
Pregabalin floating SR Tablet
Sulfuric acid Quetiapine SR Tablet

CONTACT US

Phone: +86-186 0127 8277
Tel: +86-010-5086 8470-8001 
Fax: +86-010-5086 8474 
Email:  fukangren@vip.163.com  
Skype:wangjinjingxxx 
Add: No. 30 Jinxing Rd, Daxing District, Beijing, China

COOPERATION

Corporation and many domestic well-known colleges and universities and factory establishment strategy cooperation. Corporation and more than 100 factory establishment friendly cooperative relationship.

SUBSCRIBE TO EMAIL

JOIN US

Fukang kernel carries out “ The absolute sincerity service, the science innovate ” The faith, the absolute sincerity cooperation, dares to innovate. The present Fukang kernel is being at the high speed development phase, invites steadfast, to have the innovative spirit outstanding talent diligently honestly to join us.